Clin2
NCT06648837Possibly a fitNot yet recruiting

Checking blood thinner levels during donation

Pulmonary Embolism (Diagnosis)Deep Vein ThrombosisAtrial Fibrillation (AF)

Part of Heart & circulation, Lungs & breathing clinical trials.

This trial tests a new device that might make monitoring warfarin levels easier during blood donation. It could help you manage your blood thinner treatment more conveniently.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,500 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Are 18 years or older
  • Currently taking the blood thinner warfarin
  • Have not taken heparin (another type of blood thinner) in the last 7 days
  • Not pregnant or have not been pregnant in the last 12 months
  • Do not have HIV, hepatitis, tuberculosis, or a tropical disease
  • Do not use intravenous drugs

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06480994Recruiting
Testing a new tool to help diagnose blood clots

This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.

Niort, Sartres
NCT07626411Recruiting· Phase 3
Blood Thinner Study for Irregular Heartbeat

This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.

Alexander City, Alabama
NCT06886516Recruiting· Early Phase 1
Blood thinner study for cancer patients with low platelets

This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.

Boston, Massachusetts
NCT07175428Recruiting· Phase 2
Safety of a New Blood Thinner in AFib Patients

This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.

Dothan, Alabama
NCT03773159Recruiting
Testing a blood clot test using whole blood flow

This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.

Besançon
NCT06582563Not yet recruiting
Measuring blood clotting times in patients on blood thinners

This study is testing a new device that may quickly measure how well your blood clots while you are on a blood thinner. They will take a small blood sample to see if the device works well for patients like you.

Leuven

Hear when a new Pulmonary Embolism (Diagnosis) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.